Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation

Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation

Case of a patient with acute myeloid leukemia (AML) positive for mutations in both genes NPM1 and FLT3-ITD who underwent two allogeneic haematopoietic stem cell transplants (HSCT); the second allograft one was followed by extramedullary relapse (granulocytic sarcoma of right breast), with blast cell...

Full description

Bibliographic Details
Main Authors: R. Iannotta, M. Celentano, S. Marotta, C.M. Pedata, C. Riccardi, I. Migliaccio, A. Viola, S.M. Muggianu, C. Falco, D Bovenzi, F. Ferrara, A. Picardi
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Leukemia Research Reports
Subjects:
Gilteritinib
Extramedullary relapse FLT3 ITD positive
HSCT allogeneic haematopoietic stem cell transplants
Acute myeloid leukemia FLT3 ITD positive
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048922000528

Internet

http://www.sciencedirect.com/science/article/pii/S2213048922000528

Similar Items